ELISA kit for detection and quantification of NGAL in animal research models. Designed for preclinical studies investigating acute kidney injury biomarkers.
Manufactured by
BioPorto Diagnostics
United States
ProNephro AKI (NGAL) is designed to aid in the risk assessment of acute kidney injury (AKI) in ICU patients 3 months to 22 years. A low NGAL value indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications. Elevated NGAL values signal a high risk of developing AKI and can trigger nephrology consults and interventions 2-3 days before serum creatinine rises.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 4 closest product alternatives
Bio Preventive Medicine Co. Ltd. · Taiwan
A consumable kit for collecting and processing urine samples for kidney disease prognostic testing. The kit contains all necessary materials for sample preparation and biomarker analysis in clinical and laboratory settings.
OneCheck Biotech Co., Ltd. · China
Animal-derived serum for use as blocking agents and supplementary components in immunoassays. Supports assay optimization and protocol development.
Equitech-Bio, Inc. · United States
Guinea pig-derived albumin for laboratory research applications. Suitable for immunological assays and comparative protein studies.
1 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products